Enoxaparin is a low molecular weight heparin, a form of the blood thinner heparin made of smaller pieces. It mostly blocks factor Xa, a clotting protein, and acts much less on thrombin (factor IIa) than standard heparin does. With these clotting proteins held back, the body forms clots more slowly.
Its effect peaks 3 to 5 hours after a shot under the skin, and nearly all of the injected dose reaches the blood. The liver breaks down most of it and the kidneys remove the rest, so it builds up and raises bleeding risk in people with weak kidneys. Because it slows clotting, bleeding is its main risk, including bleeding around the spine after spinal or epidural anesthesia that can cause lasting paralysis. Protamine, given into a vein, can largely reverse it after an overdose.